These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 36465438)

  • 1. Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease.
    Kavurma MM; Bursill C; Stanley CP; Passam F; Cartland SP; Patel S; Loa J; Figtree GA; Golledge J; Aitken S; Robinson DA
    Front Cardiovasc Med; 2022; 9():1054576. PubMed ID: 36465438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local association between endothelial dysfunction and intimal hyperplasia: relevance in peripheral artery disease.
    Heinen Y; Stegemann E; Sansone R; Benedens K; Wagstaff R; Balzer J; Rassaf T; Lauer T; Kelm M; Heiss C
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25648609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NADPH Oxidases, Angiogenesis, and Peripheral Artery Disease.
    Manuneedhi Cholan P; Cartland SP; Kavurma MM
    Antioxidants (Basel); 2017 Jul; 6(3):. PubMed ID: 28704938
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiangiogenic VEGF
    Ganta VC; Choi M; Farber CR; Annex BH
    Circulation; 2019 Jan; 139(2):226-242. PubMed ID: 30586702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress and Arterial Dysfunction in Peripheral Artery Disease.
    Ismaeel A; Brumberg RS; Kirk JS; Papoutsi E; Farmer PJ; Bohannon WT; Smith RS; Eidson JL; Sawicki I; Koutakis P
    Antioxidants (Basel); 2018 Oct; 7(10):. PubMed ID: 30347720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute mitochondrial antioxidant intake improves endothelial function, antioxidant enzyme activity, and exercise tolerance in patients with peripheral artery disease.
    Park SY; Pekas EJ; Headid RJ; Son WM; Wooden TK; Song J; Layec G; Yadav SK; Mishra PK; Pipinos II
    Am J Physiol Heart Circ Physiol; 2020 Aug; 319(2):H456-H467. PubMed ID: 32706261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of miR29a improves impaired post-ischemic angiogenesis in hyperglycemia.
    Chen L; Okeke E; Ayalew D; Wang D; Shahid L; Dokun AO
    Exp Biol Med (Maywood); 2017 Aug; 242(14):1432-1443. PubMed ID: 28637396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial dysfunction: a key to the pathophysiology and natural history of peripheral arterial disease?
    Brevetti G; Schiano V; Chiariello M
    Atherosclerosis; 2008 Mar; 197(1):1-11. PubMed ID: 18076886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review of the pathophysiology and potential biomarkers for peripheral artery disease.
    Krishna SM; Moxon JV; Golledge J
    Int J Mol Sci; 2015 May; 16(5):11294-322. PubMed ID: 25993296
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arterial dysfunction and functional performance in patients with peripheral artery disease: a review.
    Coutinho T; Rooke TW; Kullo IJ
    Vasc Med; 2011 Jun; 16(3):203-11. PubMed ID: 21447607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial reactivity and cardiac risk factors in older patients with peripheral arterial disease.
    Yataco AR; Corretti MC; Gardner AW; Womack CJ; Katzel LI
    Am J Cardiol; 1999 Mar; 83(5):754-8. PubMed ID: 10080432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease.
    Wieczór R; Gadomska G; Ruszkowska-Ciastek B; Stankowska K; Budzyński J; Fabisiak J; Suppan K; Pulkowski G; Rość D
    J Zhejiang Univ Sci B; 2015 Nov; 16(11):948-56. PubMed ID: 26537213
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on the pathophysiology and medical treatment of peripheral artery disease.
    Golledge J
    Nat Rev Cardiol; 2022 Jul; 19(7):456-474. PubMed ID: 34997200
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In concomitant coronary and peripheral arterial disease, inflammation of the affected limbs predicts coronary artery endothelial dysfunction.
    Brevetti G; Piscione F; Cirillo P; Galasso G; Schiano V; Barbato E; Scopacasa F; Chiariello M
    Atherosclerosis; 2008 Dec; 201(2):440-6. PubMed ID: 18358480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the relationship between flow-mediated vasodilation and radial artery tonometry in peripheral artery disease.
    Zahner GJ; Spaulding KA; Ramirez JL; Schaller MS; Walker SC; Hills NK; Gasper WJ; Grenon SM
    J Surg Res; 2018 Apr; 224():121-131. PubMed ID: 29506827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of small animal peripheral artery disease models: recent advancements and translational potential.
    Lin JB; Phillips EH; Riggins TE; Sangha GS; Chakraborty S; Lee JY; Lycke RJ; Hernandez CL; Soepriatna AH; Thorne BR; Yrineo AA; Goergen CJ
    Int J Mol Sci; 2015 May; 16(5):11131-77. PubMed ID: 25993289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic angiogenesis for revascularization in peripheral artery disease.
    Grochot-Przeczek A; Dulak J; Jozkowicz A
    Gene; 2013 Aug; 525(2):220-8. PubMed ID: 23566831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial growth factor and tissue factor in patients with established peripheral artery disease: a link between angiogenesis and thrombogenesis?
    Makin AJ; Chung NA; Silverman SH; Lip GY
    Clin Sci (Lond); 2003 Apr; 104(4):397-404. PubMed ID: 12653684
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.